 Boston Scientific Corp. BSX, -0.82 said Tuesday it has agreed to acquire Apollo Endosurgery Inc. APEN, for 10 a share, or about 615 million in cash. The news sent Apollos stock, which closed Monday at 6, up 61 in premarket trade. 